As research on intestinal microbes continues, probiotics are flooding the market. The industrial applications of probiotics continue to flourish. So far, the application of probiotics has covered many aspects such as fermented foods, dietary supplements, health care products additives, and animal feed additives.

As research on intestinal microbes continues, probiotics are flooding the market. The industrial applications of probiotics continue to flourish. So far, the application of probiotics has covered many aspects such as fermented foods, dietary supplements, health care products additives, and animal feed additives.

"Probiotics" comes from the Greek word "probios", which means for life. According to the definitions of the World Health Organization and the Food and Agriculture Organization of the United Nations, probiotics are living microorganisms that are beneficial to the host when ingested in sufficient quantities. The lactic acid bacteria that we are familiar with are the most important type of probiotics, and the prebiotics that people often say are the nourishment for probiotics, which have a beneficial effect on the body by promoting the growth and reproduction of probiotics.

Probiotics have the functions of regulating the body's homeostasis, enhancing the body's immune function, and maintaining human health. However, excessive probiotics are also risky, which may cause an imbalance of the intestinal flora. Therefore, the proportion of probiotics is highly correlated with human health.

In recent years, probiotic products have appeared on the market in an overwhelming amount. From yogurt to chocolate, from medicines to dietary supplements, probiotic products are more and more accepted and recognized by consumers-companies have made the move by deploying probiotic products. Marching into the big health industry, the probiotic market has developed rapidly. Judging from the scale of the global probiotic consumption market, the scale of the probiotic consumption market has maintained continuous growth. In 2018, the global probiotic consumption market was 49.4 billion U.S. dollars and is expected to reach 69.2 billion U.S. dollars in 2023. The probiotic industry has a bright future.

From the perspective of application, the downstream products of the probiotic industry can be divided into three main categories:

1. Functional food that is fermented by probiotics and added with active probiotics in the later stage. Including yogurt, lactic acid bacteria drinks, probiotics solubilized beans, soft sweets, etc. This is the category with the largest share of the entire probiotic market.

2. Dietary supplements. Including intestinal products, digestive drugs, etc.

3. Raw materials such as animal feed, fruit and vegetable fermentation broth.

In addition to the three major categories of products, daily chemical products have also differentiated and developed a variety of product forms. Such as skin care products and mouthwashes. Functional foods and daily chemical products are the most common product categories for venture capital companies.

With the continuous breakthroughs in scientific research related to probiotics, the technological innovation of probiotics in the breeding of their superior strains and industrial application has promoted the wide application of probiotics in dairy products, traditional foods and health foods, which is different from traditional beverages. The food market is mainly concerned with intestinal health and immune function enhancement. Nowadays, the development of probiotic functional foods shows two major trends.

The first is the specialization of efficacy: consumers first consumed lactic acid bacteria beverages, and later developed to consume fermented milk, etc. The efficacy (concentration) of probiotics gradually increased.

The second is functional subdivision: the function of probiotics was first to regulate the intestinal tract, and later developed to regulate body weight, treat periodontitis, improve hay fever, beauty and other functions.

For probiotics R&D manufacturers, the identification, screening and isolation of strains are all mature technologies. However, the barrier lies in the cultivation of targeted strains and the continuous construction of strain libraries. For a strain with a healthy brand name, the application for a function requires investment of millions of funds and an application period of about three years, while the clinical trial of the drug brand strain takes longer. Therefore, upstream companies that can continue to cultivate star strains with specific functions and a wide range of uses will be more likely to be favored by capital.

Author's Bio: 

Creative Enzymes is a remarkable supplier and manufacturer in the Enzymology field. Equipped with advanced technique platform, Creative Enzymes is able to offer high-quality and professional services for customers. Its products and services are widely used in the academic and pharmaceutical industries.